CASPOFUNGINA GALENICUM HEALTH 50 mg Romanya - Romence - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

caspofungina galenicum health 50 mg

pharmadox healthcare, ltd - malta - caspofunginum - pulb. pt. conc. pt. sol. perf. - 50mg - antimicotice de uz sistemic alte antimicotice sistemice

CASPOFUNGINA GALENICUM HEALTH 70 mg Romanya - Romence - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

caspofungina galenicum health 70 mg

pharmadox healthcare, ltd - malta - caspofunginum - pulb. pt. conc. pt. sol. perf. - 70mg - antimicotice de uz sistemic alte antimicotice sistemice

CASPOFUNGINA STADA M&D 50 mg Romanya - Romence - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

caspofungina stada m&d 50 mg

sag munufacturing s.l. - spania - caspofunginum - pulb. pt. conc. pt. sol. perf. - 50mg - antimicotice de uz sistemic alte antimicotice sistemice

CASPOFUNGINA STADA M&D 70 mg Romanya - Romence - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

caspofungina stada m&d 70 mg

sag munufacturing s.l. - spania - caspofunginum - pulb. pt. conc. pt. sol. perf. - 70mg - antimicotice de uz sistemic alte antimicotice sistemice

Kinpeygo Avrupa Birliği - Romence - EMA (European Medicines Agency)

kinpeygo

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiareice, antiinflamatoare intestinale / antiinfective agenți - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.

BUPROFESS 400 mg Romanya - Romence - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

buprofess 400 mg

stada arzneimittel ag - germania - ibuprofenum - caps. moi - 400mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic

Ximluci Avrupa Birliği - Romence - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

RIVAROXABAN STADA 10 mg Romanya - Romence - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rivaroxaban stada 10 mg

stada arzneimittel ag - germania - rivaroxabanum - compr. film. - 10mg - antitrombotice inhibitori directi ai factorului xa

RIVAROXABAN STADA 15 mg Romanya - Romence - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rivaroxaban stada 15 mg

stada arzneimittel ag - germania - rivaroxabanum - compr. film. - 15mg - antitrombotice inhibitori directi ai factorului xa

RIVAROXABAN STADA 15 mg+20 mg Romanya - Romence - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rivaroxaban stada 15 mg+20 mg

stada arzneimittel ag - germania - rivaroxabanum - compr. film. - 15mg+20mg - antitrombotice inhibitori directi ai factorului xa